Compare Amphastar Pharmaceuticals Inc (AMPH) vs Stitch Fix Inc (SFIX) Price & Performance
Price performance
Price movement over the last 24 hours
Key statistics
Key statistics
Amphastar Pharmaceuticals Inc vs Stitch Fix Inc — how do they compare? Amphastar Pharmaceuticals Inc trades at $18.72 (market cap $826.08M), while Stitch Fix Inc trades at $3.57 (market cap $475.00M). The key difference: Amphastar Pharmaceuticals Inc is the larger of the two by market cap. Which is the better fit depends on your goals.
| AMPH | SFIX | |
|---|---|---|
Market Cap | $826.08M | $475.00M |
Sector | Health | Consumer Cyclical |
52-Week High | $30.81 | $5.83 |
52-Week Low | $16.87 | $3.06 |
Enterprise Value | $1.22B | $362.71M |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
AMPH trades at $18.72, down 1.58% with bearish technical signals despite oversold RSI readings. The company reported mixed Q1 2026 results with EPS of $0.42 missing estimates of $0.70, continuing a trend of recent earnings disappointments. Valuation metrics appear reasonable with P/E of 11.29 and P/B of 1.07, while profitability remains solid with 47.34% gross margins. Recent news includes a Zacks Strong Sell rating and ongoing securities law investigation.
The stock faces near-term headwinds from earnings misses and negative analyst sentiment, though current valuations provide some downside protection. Upside potential exists if the company can execute its strategic pivot to proprietary drugs and biosimilars while managing BAQSIMI discount pressures. Key risks include ongoing legal scrutiny and competitive pressures in the generic drug market.
Stitch Fix (SFIX) trades at $3.56, up 1.14% today, showing signs of a potential turnaround despite technical bearish signals. The company has demonstrated improving fundamentals with three consecutive quarterly earnings beats and narrowing losses, while revenue has stabilized around $1.3 billion. Recent news highlights AI-driven personalization initiatives and growing client spending, though the stock remains near historic lows with a bearish technical outlook.
The outlook suggests cautious optimism as SFIX executes its turnaround strategy, with analyst consensus pointing to 33% upside potential. Key risks include ongoing net losses, competitive pressures in online retail, and execution challenges in maintaining client growth momentum. The stock presents a high-risk opportunity for investors betting on the company's AI-driven personalization strategy and margin improvement trajectory.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Amphastar Pharmaceuticals Inc
Amphastar is a specialty pharmaceutical company that develops and markets injectable, intranasal, and inhalation products. Its portfolio includes both complex generic drugs and proprietary delivery systems.
Read more on AMPH →About Stitch Fix Inc
Stitch Fix Inc offers personal style service for men and women. The company engages in delivering one-to-one personalization to clients through the combination of data science and human judgment. It provides a shipment service called A FIX where the stylist's hand selects items from several merchandises with analysis of client and merchandise data to provide a personalized shipment of apparel, shoes, and accessories suited to the client's needs. The company offers products across categories, brands, product types and price points including Women's, Petite, Maternity, Men's and Plus. It also offers various product types, including denim, dresses, blouses, skirts, shoes, jewelry and handbags, and sells merchandise across various range of price points.
Read more on SFIX →
